Jan Eickhoff - Concepedia

Author

Jan Eickhoff

Also Known As

Eickhoff, Jan, Eickhoff, Jan Eike, J EICKHOFF, J Eickhoff, J. Eickhoff, Jan E. Eickhoff, Jan Eickhoff, Jan Eike Eickhoff

Publications

Citations

H-Index

Concepts

All Affiliations

Lead Discovery Center (Germany)Friedrich-Alexander-Universität Erlangen-Nürnberg Max Planck Institute of Biochemistry UNSW Sydney Freie Universität Berlin

About

Jan Eickhoff is an author at Lead Discovery Center (Germany) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.6K
2	Natural Sciences	4	4	193
3	Biochemistry	3	3	758
4	Engineering	1	1	26
5	Biomedical Engineering	1	1	26

Jan Eickhoff

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Gasdermin D plays a vital role in the generation of neutrophil extracellular traps Gabriel Sollberger, Axel Choidas, Garth L. Burn, Science Immunology ApoptosisImmunologyGasdermin DCell DeathNet Formation	2018	702
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells Magdalena Paolino, Axel Choidas, Stephanie Wallner, Nature Cell SignalingMedicineImmunologyTam ReceptorsImmune Checkpoint Inhibitor	2014	449
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer Ulrich Lücking, Arne Scholz, Philip Lienau, ChemMedChem	2017	176
Characterization of molecular and cellular functions of the cyclin‐dependent kinase <scp>CDK9</scp> using a novel specific inhibitor Thomas Albert, Caroline Rigault, Jan Eickhoff, British Journal of Pharmacology	2013	120
A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations Corina Hutterer, Jan Eickhoff, Jens Milbradt, Antimicrobial Agents and Chemotherapy	2015	104
Proteomic Characterization of the Angiogenesis Inhibitor SU6668 Reveals Multiple Impacts on Cellular Kinase Signaling Klaus Godl, Oliver J. Gruß, Jan Eickhoff, Cancer Research Drug TargetCellular Kinase SignalingTumor BiologyAngiogenesisSignaling Pathway	2005	103
Cyclin-Dependent Kinase 7 Controls mRNA Synthesis by Affecting Stability of Preinitiation Complexes, Leading to Altered Gene Expression, Cell Cycle Progression, and Survival of Tumor Cells Timothy W. R. Kelso, Karen Baumgart, Jan Eickhoff, Molecular and Cellular Biology ImmunologyCell CycleCancer BiologyTumor BiologySignaling Pathway	2014	80
Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo Mark R. Schleiss, Jan Eickhoff, Sabrina Auerochs, Antiviral Research Antiviral CompoundMedicineImmunologyAntiviral Drug DevelopmentAntiviral Therapy	2008	79
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo Lydia Reinhardt, Susanne Kordes, Peter Reinhardt, Stem Cell Reports	2019	68
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma Johannes Brägelmann, Marcel A. Dammert, Felix Dietlein, Cell Reports	2017	53

Page 1